and high 28-d mortality rate [6] ". Since ACLF affects approximately 30% of hospitalised cirrhotic patients, ACLF is the most frequent indication for admission to the ICU [4, 5] . However, the mortality among patients admitted to the ICU with ACLF is high [7] . Consequently, clinical awareness on identification of cirrhotic patients at risk of developing organ failure, who will benefit from early intensive care treatment, is of great importance. The mortality among patients admitted to the ICU with ACLF ranges between 35%-93% [2, 5, 7] . Patients requiring mechanical ventilation are high-risk patients with poor long-term survival with a 1-year mortality rate of 89% [8] . Kavli et al [7] have shown that among patients with clinical or histological diagnosed alcoholic liver cirrhosis, in need for intensive care treatment, the 90-d mortality reaches levels of up to 93%, dependent on the degree of organ system failure [7] . Due to the poor prognosis the utilization of organ support in the ICU for these patients is often questioned. The treatment of patients with ACLF, not eligible for liver transplantation, is complicated and must be managed with therapies, which require a highly specialized team and close collaboration between hepatologists and intensive care specialists. There is a need for clinical tools and a proper triage to guide the physicians in decision making regarding the allocation of patients with ACLF to ICU, admitting only patients who would likely benefit from intensive care treatment [7] . In this study we aimed to perform a systematic review regarding allocation of patients with liver cirrhosis to intensive care, and to propose a decision tool for clinical practice.
MATERIALS AND METHODS
An electronic search was performed in PubMed, MEDLINE and EMBASE. Studies were included in the search irrespective of blinding, publication status, or language, and manual searches including scanning of reference lists in relevant articles and conference proceedings was also performed. All studies responding to the issue of this article were eligible for analysis, including previous reviews.
Criteria for considering studies for this review
The present systematic search includes studies on hospitalized patients with cirrhosis and organ failure or acute on CLIF and/or intensive care therapy.
Search methods for identification of studies
String 1: "liver cirrhosis" or "hepatic cirrhosis"; String 2: "liver failure" or "hepatic failure"; String 3: "intensive care" or "intensive treatment" or "intensive therapy" or "critical care".
Potentially eligible studies were listed and evaluated. After reading the titles and abstracts, clearly irrelevant trials were excluded. Afterwards relevant full text studies were evaluated, and the eligible studies
INTRODUCTION
The incidence of liver cirrhosis is increasing [1, 2] . In the western world liver cirrhosis is mainly related to the increasing burden of alcohol-related liver disease, nonalcoholic fatty liver disease and currently also hepatitis C, in the eastern world hepatitis B is a main cause. Patients with liver cirrhosis are prone to a progressive deterioration with the occurrence of portal hypertension and hepatic failure leading to end-stage liver disease and the development of complications. Furthermore, a large group (up to 75%) of patients are first diagnosed with liver cirrhosis, when experiencing their first episode of decompensation, and thus these patients represents a large hidden burden of the disease [3] . Patients with advanced liver cirrhosis, frequently require admission to intensive care unit (ICU) [4] , mainly for various complications of advanced liver disease (i.e., sepsis, variceal bleeding, hepatic encephalopathy, spontaneous bacterial peritonitis, hepato-renal syndrome). These complications are associated with high risk of organ failures and a high mortality. Patients with cirrhosis presenting with acute hepatic deterioration and progressive organ failure represent the, now well described, syndrome acute-on-chronic-liver failure (ACLF) [5, 6] . The Chronic Liver Failure (CLIF) ACLF in cirrhosis (CANONIC) study investigators of the European Association for the Study of the Liver -Chronic Liver Failure Consortium (EASL-CLIF) originally introduced the concept of ACLF: "ACLF is based on the presence of three major characteristics of the syndrome; acute decompensation, organ failure [predefined by the Clif Sequential Organ Failure Assessment (SOFA) score] were selected (Figure 1 ).
RESULTS
The initial search identified 660 articles, 402 articles were indexed in PubMed, and 258 indexed in EMBASE. After duplicates were removed 584 articles, were evaluated for relevance.
During the initial title screening process 505 articles where evaluated by title of the first author, and found not relevant for the specific topic of this article, and therby excluded from the study. Further 67 articles were excluded after reading the abstracts, leaving 12 potentially relevant articles to be evaluated in full text together with a review of references in these articles. Ultimately, five articles were selected; two cohort studies and three reviews were found in the systematic search to be eligible for the present review ( Figure 1) . Table 1 summarizes the main findings of the included studies.
Cohort studies
Kavli et al [7] performed a retrospective cohort study including 87 patients admitted to an ICU, at a university hospital with primary and secondary referrals. They found that increasing numbers of organ failures, correlate with increased mortality in critically ill patients with alcoholic liver cirrhosis. Interestingly they found that in patients with 3 or more organ failures the ICU mortality was > 90% (Table 1) . Furthermore, they found the prognostic scores specific for critical illness to be superior at predicting outcome compared to the liver-specific Child-Pugh score. Shawcross et al [1] performed a prospective analysis of 563 patients admitted to a liver ICU with diagnosis of cirrhosis and dysfunction of one or more extrahepatic organ(s). They assessed resource utilization and found that presence of organ failure resulted in considerable resource expenditure in patients with liver cirrhosis, but had hospital mortality of 59% as illustrated in Table 1 .
Reviews
Ginès et al [9] performed a review with focus on the diagnostic approach and the currently recommended treatment strategy of critically ill cirrhotic patients. They report no new data, and no methods section is described. However, they describe that several studies have shown that relatively good results can be obtained in selected critically ill cirrhotic patients, and therefore reluctance to refer these patients to the ICU should be balanced. [10] performed a review within the field of cirrhotic patients and allocation to ICU. They reported no new data, and the methods section was sparsely described. They suggest that an aggressive approach to organ support is justified, and that further discussions between hepatologists and intensive care specialists are required to determine acceptable burden-to-benefit ratios for prolonged intensive care support in young alcoholic patients. Saliba et al [11] performed a review within the field of cirrhotic patients and allocation to ICU. They reported no new data, and no methods section was described. However, they claimed that general ICU prognostic scores [SOFA score, Acute Physiology and Chronic Health Evaluation (APACHE) Ⅱ and SAPS Ⅱ] predicted mortality better than liver specific scores (MELD and Child-Pugh score) in cirrhotic patients, once admitted to the ICU. Furthermore, ICU and liver scores predicted outcome more precisely once they were re-evaluated at day 3 from admission. The authors stated that patients should be referred from the hepatology ward to the ICU at an earlier stage of decompensation, and a multidisciplinary approach between hepatologists, intensive care specialists, and also transplant surgeons should be mandatory.
Scoring systems
A number of score systems have been developed to assess the prognosis of critically ill cirrhotic patients, In hospital mortality
ICU mortality
Kavli et al [7] , 2012, Denmark, cohort study This study investigated the severity of organ failure, and the frequency and outcome of withholding therapy in patients with advanced alcoholic liver cirrhosis admitted to a Scandinavian ICU Shawcross et al [1] , 2012, United Kingdom, cohort study [10] , see Table 2 [2, . The liver specific scores have mainly focused on the general prognosis of cirrhotic patients, whereas the general scores, such as APACHE score, and SOFA score, were developed to predict outcome in the general population admitted to the ICU [5, 14, 20] . Numerous organ-failure scores have been developed to evaluate the prognosis depending on the number of organ failures, however, only a limited number of score systems have been established in clinical practice. To assess severity and prognosis due to underlying liver disease before ACLF or acute hospitalization, ChildPugh score and MELD score are the best-validated scores [14] . The World Health Organization (WHO) performance status (PS) is also useful to grade general well-being and activities of daily life. The prognostic liver specific score named ChildPugh score (Table 3) contains five components; grade of hepatic encephalopathy, presence of ascites, serum-bilirubin, serum-albumin, and the international normalized ratio for prothrombin time (INR) [36] .
Child Pugh score
The Child-Pugh score has been well established in clinical practice for decades. It contains a limited number of variables, is simply calculated, and is easily interpreted. The score is a simple method for determining the prognosis of patients with cirrhosis [15] . However, the Child-Pugh score does not take factors such as cardiovascular, renal, and pulmonary dysfunction into account, consequently it does not offer valid information to predict mortality in cirrhotic patients who have organ failure [14] . Further, the assessment of hepatic encephalopathy and presence of ascites are subjective measures and prone to observer variation.
MELD score
The MELD score is a scoring system for assessing the severity of chronic liver disease. The MELD Score ranges from 6 (less sick) to 40 (very sick) and the formula is based on the natural logarithm of serum bilirubin, serum creatinine, the INR for prothrombin time, and information regarding dialysis [37] . The MELD score is widely used to quantify end-stage liver disease in patients listed for liver transplantation [15] , and has been repeatedly shown to be equivalent or even superior to the Child-Pugh score to estimate shortterm survival among cirrhotic patients [14] . An additional advantage of MELD is the exclusion of subjective measures.
WHO performance score
The performance score was originally introduced in the treatment of cancer patients, as an attempt to quantify cancer patients' general well-being and activities of daily life (Table 4 ) [38] . The score is widely used in other medical conditions as a simple measure of general condition, functional ability and quality of life.
APACHE scores
The APACHE score is one of several ICU scoring systems. The score is a severity-of-disease classification system, based on 12 physiological parameters; 1, alveolar-arterial O2 tension difference (AaDO2) or arterial oxygen tension (PaO2) (depending on the fraction of inspired oxygen); 2, temperature (rectal); 3, mean arterial pressure; 4, arterial pH; 5, heart rate;,
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6, respiratory rate; 7, sodium (serum); 8, potassium (serum); 9, Creatinine; 10,. Haematocrit; 11, white blood cell count; and 12; Glasgow Coma Scale. The score is applied within 24 h of admission to the ICU, the higher the score, the higher risk of death [15] . Compared to Child-Pugh scores it has been shown in numerous studies to be more powerful in predicting hospital mortality in patients with liver cirrhosis. Wehler et al [39] found an areal under the receiver operating curve (AUROC) of 0.79 for the APACHE Ⅱ score, compared to Child-Pugh with an AUROC of 0.73, other studies have found similar results [24] [25] [26] 28] .
SOFA Score and CLIF-SOFA
The SOFA score was developed as a simple prognostic score to evaluate the degree of organ failure in patients in the general ICU [2, 29] . The score contains information on degree of failure regarding liver, kidney, brain, coagulation, circulation and lungs, graded from 0-4 ( Table 5 ). The CLIF-SOFA score is a modified version of the original SOFA score, a newly developed scoring system exclusively for patients with end-stage liver disease, and it accommodates a lower threshold for serum creatinine, because minor increases in s-creatinine levels in cirrhotic patients indicate marked reductions in glomerular filtration rate. Furthermore, it uses the INR instead of platelets as a marker of coagulaopathy, increases the threshold for bilirubin to achieve organ failure, and uses grades of hepatic encephalopathy from the West Haven score as opposed to Glasgow Coma Scale for neurologic failure [2, 6] . Organ failure in the CLIF SOFA score is defined as; liver failure: bilirubin > 205 µmol/L, kidney failure: creatinine > 177 µmol/L or requiring renal replacement therapy, neurologic failure: hepatic encephalopathy grade 3 or 4, coagulation failure: INR > 2.5, and circulation failure: requiring vasopressors to maintain adequate mean arterial pressure (MAP). The CLIF-SOFA score can be translated into a degree of ACLF [6, 40] (Figure 2 , Tables 5 and 6 ).
Royal Free Hospital score
The Royal Free Hospital (RFH) score is a novel prognostic model for critically ill patients with cirrhosis. Parameters included in the score are bilirubin, INR, lactate, urea, A-a gradient, and variceal bleeding. Theocharidou et al [18] , found the RFH score to have good discriminative power, equally to the CLIF-SOFA and SOFA score, however, the score remains to be externally validated, to confirm the clinical utility.
DISCUSSION
The decision-making regarding allocation of cirrhotic patients to ICU remains a great interdisciplinary challenge in daily clinical practice. The literature is scarce and no studies specifically address this issue. There is general consensus that selection criteria for ICU admission candidates should be developed and validated for this group of patients and multidisciplinary approach is mandatory. However, all together the general approach throughout the literature is somewhat indefinable. It still remains to be determined, which cirrhotic patients will benefit from intensive care treatment, and if so, when during admission they should be transferred to the ICU, and contrary when intensive treatment is futile and should be withheld.
It has been known for more than 40 years that surgical procedures on cirrhotic patients is associated with increased risk [35] , and for cirrhotic patients (child-pugh C) who undergo nontransplant surgical procedures, mortality rates of up to 76% have been reported [41] . Furthermore it is known that the mortality rate is markedly increased for emergency surgery (57%) compared to elective surgery (10%) [42] . Higher
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risk of infection, coagulopathy and malnutrition may be important factors [43] [44] [45] [46] [47] . In addition many cirrhotic patients decompensate in the postoperative phase and develop hepatic encephalopathy, ascites, hepato-renal syndrome or infections [44, 45, 47, 48] . Reduced perfusion of the liver and altered response to anaesthetics and other medications, may also be contributing factors [49, 50] . It is therefore essential to assess the severity of the underlying liver disease and to perform preoperative optimisation, including treatment of coagulopathy, ascites, portal hypertension, malnutrition, any substance abuse problem and infections.
Based on current available data [5, 6] , we have developed an algorithm based on three scoring systems: Child-Pugh Score, MELD score and CLIF-SOFA score. In Figure 3 we suggest criteria to determine if a patient is a candidate to intensive care if needed. However, the algorithm remains to be validated in clinical practice.
The exact time point when patients should be referred to intensive care may be difficult to identify and will likely depend on local clinical setup, i.e., access to intermediate care. However, the following general consideration can be used. Dialogue between physicians from the referring ward and ICU is mandatory and should be initiated at an early stage to assess if the patient is candidate to intensive care if needed and to ensure detection and treatment of organ failures as early as possible.
Close monitoring of progressive organ dysfunction in the ward is essential. Sometimes it may also be rational to transfer patients to the intermediate care/ICU to prevent occurrence of organ failure by close monitoring. Referral criteria should include the following: (1) Comatose patients not able to protect airways; (2) Respiratory failure with need of mechanical ventilation; (3) Circulatory failure with systolic blood pressure < 90 mmHg or low mean arterial pressure (MAP < 60 mmHg) despite adequate fluid supplementation and increasing lactate or increasing creatinine or reduced urine output; (4) necessity of vasopressors; and (5) septic shock or multi-organ failures.
To help the daily registration of important values in patients with liver cirrhosis, we have developed a specific computer software program First Chronic Liver Allocation Scoring System (First-CLASS).
First-CLASS features an extensive data-gathering 8970 August 7, 2015|Volume 21|Issue 29| WJG|www.wjgnet.com tool, with a user-friendly graphical interface, for the purpose of scoring acute on CLIF patients. An immediate score of the patient is calculated using the described algorithm, and it will be presented to the user. All data is saved to a database, which can be easily retrieved for both research and evaluation of specific patients. First-CLASS provides a program for viewing the data that has been collected in a meaningful way, such as using graphs for visualization of results in the given admission period. Furthermore the First-CLASS-Viewer program allows for exporting the data of patients to be used directly for statistical analysis (Figure 4 ).
In conclusion, we found that the literature regarding allocation of cirrhotic patients to ICU is very limited and no studies have proposed and tested any specific allocation criteria. Thus it still remains to be determined, which cirrhotic patients will benefit from intensive care treatment, and if so, when during admission they should be transferred to the ICU, and when intensive treatment is futile and should be withheld. Based on indirect evidence we have proposed a scoring system that can help identify which patients are candidates or not to ICU therapy, however the system needs validation.
COMMENTS

Background
Patients with liver cirrhosis are prone to a progressive disease course with the occurrence of portal hypertension and hepatic failure leading to end-stage disease and development of complications. Cirrhosis and organ failure is associated with a high mortality. Rational and timely allocation to an intensive care unit (ICU) is a challenge of clinical importance.
Research frontiers
The exact time point when patients should be referred to intensive care may be difficult to identify and will likely depend on local clinical setup, i.e., access to intermediate care. Close monitoring of progressive organ dysfunction in the ward is essential. Sometimes it may also be rational to transfer patients to the intermediate care/ICU to prevent occurrence of organ failure by close monitoring. Referral criteria should include the following: (1) Comatose patients not able to protect airways; (2) Respiratory failure with need of mechanical ventilation; (3) Circulatory failure with systolic blood pressure < 90 mmHg or low mean arterial pressure (MAP < 60 mmHg) despite adequate fluid supplementation and increasing lactate or increasing creatinine or reduced urine output; (4) necessity of vasopressors; and (5) septic shock or multi-organ failures.
Innovations and breakthroughs
To help the daily monitoring and registration of organfunctions in patients with liver cirrhosis, the authors have developed computer software program First Chronic Liver Allocation Scoring System (First-CLASS). First-CLASS features an extensive data-gathering tool, with a user-friendly graphical interface, for the purpose of scoring acute on chronic liver failure (CLIF) patients. An immediate
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score of the patient is calculated using the described algorithm, and it will be presented to the user.
Applications
It still remains to be determined, which cirrhotic patients will benefit from intensive care treatment, and if so, when during admission they should be transferred to the ICU, and when intensive treatment is futile and should be withheld. Based on indirect evidence, the authors have proposed a scoring system that can help identify which patients are candidates or not to ICU therapy, however the system needs validation.
Terminology
Patients with cirrhosis presenting with acute hepatic deterioration and progressive organ failure represent the, now well described, syndrome Acute-on-Chronic-Liver Failure (ACLF). The CLIF ACLF in cirrhosis study investigators of the European Association for the Study of the Liver -Chronic Liver Failure Consortium originally introduced the concept of ACLF: "ACLF is based on the presence of three major characteristics of the syndrome; acute decompensation, organ failure (predefined by the CLIF SOFA score) and high 28-d mortality rate".
Peer-review
In this manuscript "Allocation of patients with liver cirrhosis and organ failure to intensive care: Systematic review and a proposal for clinical practice", the authors aimed to perform a systematic review regarding allocation of patients with liver cirrhosis to ICU. They also proposed a scoring system to help identify the patients as candidates for ICU therapy. The subject matter of current study is of interest. This review may help clinicians chose the more suitable treatments.
